2022, Vol. 3, Issue 1, Part A
Efficacy of Sarolaner in the treatment of generalised demodicosis in dogs
Author(s): Carmel Prins, Devadevi N, Vijayalakshmi P, Rajkumar K and Abiramy Prabavathy A
Abstract: The efficacy of a novel isoxazoline, sarolaner (Simparica™) against Demodex spp. was evaluated in six dogs with generalised demodicosis. Dogs were presented with a history of alopecia, severe pruritis and erythematous lesions on the body. Direct microscopic examination of deep skin scraping was positive for Demodex spp. The dogs were treated with single dose sarolaner chewable tablets (Simparica™) @ 2mg/kg body weight orally. All dogs showed rapid improvement after one week of treatment and completely recovered after a month. Clinically, there were no adverse effects of treatment in all cases.
Pages: 17-19 | Views: 774 | Downloads: 396
Download Full Article: Click Here
How to cite this article:
Carmel Prins, Devadevi N, Vijayalakshmi P, Rajkumar K, Abiramy Prabavathy A. Efficacy of Sarolaner in the treatment of generalised demodicosis in dogs. J Res Chem 2022;3(1):17-19.